Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 11—November 2018
Research

Norovirus Gastroenteritis among Hospitalized Patients, Germany, 2007–2012

Frank KowalzikComments to Author , Harald Binder, Daniela Zöller, Margarita Riera-Montes, Ralf Clemens1, Thomas Verstraeten, and Fred Zepp
Author affiliations: University Medical Centre of the Johannes Gutenberg University, Mainz, Germany (F. Kowalzik, H. Binder, D. Zöller, F. Zepp); P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium (M. Riera-Montes, T. Verstraeten); Takeda Pharmaceutical International AG, Zurich, Switzerland (R. Clemens)

Main Article

Table 3

Published norovirus gastroenteritis hospitalization incidence rates in selected countries in Europe and North America, 1996–2013*

Country Data source Study years Infection type or diagnostic position No. cases/10,000 population
Germany (this study)
 Retrospective analysis of DESTATIS hospitalization data
 2007–2012 Primary diagnosis 3.4
2007–2012
 Secondary diagnosis
 4.9
Germany (14)
 Retrospective analysis of RKI notification data
 2002–2008
 Nosocomial
 1.6
Germany (13)
 Retrospective analysis of RKI notification data
 2001–2009
 Community-acquired
 1.0–2.5
England (26)
 Retrospective regression analysis using PHE notification data and HES emergency admissions
 2000–2006 Community-acquired 1.0–4.3†
2000–2006
 Community-acquired
 0.23–0.48‡
England (27)
 Retrospective analysis of GP and hospital discharge databases
 2007–2013
 Any position
 6.2–8.0
The Netherlands (23)
 Retrospective analysis of national surveillance data
 2009
 Community-acquired
 1.2
United States (24)
 Retrospective regression analysis using NIS data
 1996–2007
 Any position
 2.1
Canada (25) Retrospective binomial generalized linear analysis using CIHI-HMDB data 2006–2011 Primary diagnosis 0.05
2006–2011 Other diagnosis 0.17

*CIHI-HMDB, Canadian Institutes of Health Information–Hospital Morbidity Database; DESTATIS, German Federal Statistics Office; HES, Hospital Episode Statistics; NIS, Nationwide Inpatient Sample; PHE, Public Health England; RKI, Robert Koch Institute.
†Age >65 y.
‡Age 18–64 y.

Main Article

References
  1. Lopman  BA, Steele  D, Kirkwood  CD, Parashar  UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med. 2016;13:e1001999. DOIPubMedGoogle Scholar
  2. Hemming  M, Räsänen  S, Huhti  L, Paloniemi  M, Salminen  M, Vesikari  T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–46. DOIPubMedGoogle Scholar
  3. Bucardo  F, Reyes  Y, Svensson  L, Nordgren  J. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination. PLoS One. 2014;9:e98201. DOIPubMedGoogle Scholar
  4. Payne  DC, Vinjé  J, Szilagyi  PG, Edwards  KM, Staat  MA, Weinberg  GA, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013;368:1121–30. DOIPubMedGoogle Scholar
  5. Koo  HL, Neill  FH, Estes  MK, Munoz  FM, Cameron  A, DuPont  HL, et al. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc. 2013;2:57–60. DOIPubMedGoogle Scholar
  6. Teunis  PF, Moe  CL, Liu  P, Miller  SE, Lindesmith  L, Baric  RS, et al. Norwalk virus: how infectious is it? J Med Virol. 2008;80:1468–76. DOIPubMedGoogle Scholar
  7. Johnston  CP, Qiu  H, Ticehurst  JR, Dickson  C, Rosenbaum  P, Lawson  P, et al. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis. 2007;45:534–40. DOIPubMedGoogle Scholar
  8. Lopman  BA, Reacher  MH, Vipond  IB, Hill  D, Perry  C, Halladay  T, et al. Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis. 2004;10:1827–34. DOIPubMedGoogle Scholar
  9. Lynn  S, Toop  J, Hanger  C, Millar  N. Norovirus outbreaks in a hospital setting: the role of infection control. N Z Med J. 2004;117:U771.PubMedGoogle Scholar
  10. [Revised case definitions for the submission of evidence of dengue virus and norovirus and morbidity or death from dengue fever and norovirus gastroenteritis.] [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54:246–50.PubMedGoogle Scholar
  11. Uhlig  U, Kostev  K, Schuster  V, Koletzko  S, Uhlig  HH. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines. Pediatr Infect Dis J. 2014;33:e299–304. DOIPubMedGoogle Scholar
  12. Kowalzik  F, Zepp  F, Hoffmann  I, Binder  H, Lautz  D, van Ewijk  R, et al. Disease burden of rotavirus gastroenteritis in children residing in Germany: a retrospective, hospital-based surveillance. Pediatr Infect Dis J. 2016;35:97–103.PubMedGoogle Scholar
  13. Bernard  H, Höhne  M, Niendorf  S, Altmann  D, Stark  K. Epidemiology of norovirus gastroenteritis in Germany 2001-2009: eight seasons of routine surveillance. Epidemiol Infect. 2014;142:63–74.PubMedGoogle Scholar
  14. Spackova  M, Altmann  D, Eckmanns  T, Koch  J, Krause  G. High level of gastrointestinal nosocomial infections in the german surveillance system, 2002-2008. Infect Control Hosp Epidemiol. 2010;31:1273–8. DOIPubMedGoogle Scholar
  15. Treanor  JJ, Atmar  RL, Frey  SE, Gormley  R, Chen  WH, Ferreira  J, et al. A novel intramuscular bivalent norovirus virus-like particle vaccine candidate—reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis. 2014;210:1763–71. DOIPubMedGoogle Scholar
  16. Bernstein  DI, Atmar  RL, Lyon  GM, Treanor  JJ, Chen  WH, Jiang  X, et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015;211:870–8. DOIPubMedGoogle Scholar
  17. Beckmann  MW, Juhasz-Böss  I, Denschlag  D, Gaß  P, Dimpfl  T, Harter  P, et al. Surgical methods for the treatment of uterine fibroids—risk of uterine sarcoma and problems of morcellation: position paper of the DGGG. Geburtshilfe Frauenheilkd. 2015;75:148–64. DOIPubMedGoogle Scholar
  18. Zwink  N, Jenetzky  E, Schmiedeke  E, Schmidt  D, Märzheuser  S, Grasshoff-Derr  S, et al.; CURE-Net Consortium. Assisted reproductive techniques and the risk of anorectal malformations: a German case-control study. Orphanet J Rare Dis. 2012;7:65. DOIPubMedGoogle Scholar
  19. Statistisches Bundesamt Wiesbaden. GENESIS-Online [cited 2017 Dec 15]. https://www-genesis.destatis.de/genesis/online/logon?language=de&sequenz=statistiken&selectionname=12*&usg=ALkJrhjgxiAsKejwJNMswJxtZm3-LkALkA
  20. Werber  D, Hille  K, Frank  C, Dehnert  M, Altmann  D, Muller-Nordhorn  J, et al. Years of potential life lost for six major enteric pathogens, Germany, 2004–2008. Epidemiol Infect. 2012;•••:1–8.PubMedGoogle Scholar
  21. Hall  AJ, Lopman  BA, Payne  DC, Patel  MM, Gastañaduy  PA, Vinjé  J, et al. Norovirus disease in the United States. Emerg Infect Dis. 2013;19:1198–205. DOIPubMedGoogle Scholar
  22. Medizinischer Dienst der Krankenversicherung [cited 2015 Nov 22]. http://www.mdk.de
  23. Verhoef  L, Koopmans  M. W VANP, Duizer E, Haagsma J, Werber D, et al. The estimated disease burden of norovirus in the Netherlands. Epidemiol Infect. 2012;•••:1–11.PubMedGoogle Scholar
  24. Lopman  BA, Hall  AJ, Curns  AT, Parashar  UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis. 2011;52:466–74. DOIPubMedGoogle Scholar
  25. Morton  VK, Thomas  MK, McEwen  SA. Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006-2010. Epidemiol Infect. 2015;143:3528–37. DOIPubMedGoogle Scholar
  26. Verstraeten  T, Cattaert  T, Harris  J, Lopman  B, Tam  CC, Ferreira  G. Estimating the burden of medically attended norovirus gastroenteritis: modeling linked primary care and hospitalization datasets. J Infect Dis. 2017;216:957–65. DOIPubMedGoogle Scholar
  27. Haustein  T, Harris  JP, Pebody  R, Lopman  BA. Hospital admissions due to norovirus in adult and elderly patients in England. Clin Infect Dis. 2009;49:1890–2. DOIPubMedGoogle Scholar
  28. Franck  KT, Nielsen  RT, Holzknecht  BJ, Ersbøll  AK, Fischer  TK, Böttiger  B. Norovirus genotypes in hospital settings: differences between nosocomial and community-acquired infections. J Infect Dis. 2015;212:881–8. DOIPubMedGoogle Scholar
  29. Geginat  G, Kaiser  D, Schrempf  S. Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2012;31:733–7. DOIPubMedGoogle Scholar
  30. Rogan  WJ, Gladen  B. Estimating prevalence from the results of a screening test. Am J Epidemiol. 1978;107:71–6. DOIPubMedGoogle Scholar

Main Article

1Current affiliation: Global Research in Infectious Diseases, Rio de Janeiro, Brazil.

Page created: October 16, 2018
Page updated: October 16, 2018
Page reviewed: October 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external